Valiant Laboratories LtdPharmaceuticalsINE0JWS01017Consolidated₹121.05-2.45 (-1.98%)
Valuation
Market Cap₹656.48 Cr
TTM PE40.42x
Forward PE21.13x
PEG29.72
Book Value₹61.20
P/B1.98x
TTM EPS₹2.99
Fwd EPS₹5.72
TTM Revenue₹376.50 Cr
TTM PAT₹16.21 Cr
TTM EBITDA₹35.63 Cr
TTM EBIT₹26.18 Cr
Last Qtr PAT₹0.41 Cr
Last Qtr EBITDA₹5.17 Cr
Last Qtr EBIT₹1.51 Cr
Profitability
ROE4.88%
ROCE8.36%
TTM NPM4.31%
TTM EBITDA %9.46%
Curr OPM0.35%
Last OPM18.17%
Curr NPM—
Last NPM—
Curr EPS₹0.08
Last EPS₹3.89
Balance sheet
Equity₹54.31 Cr
Reserve₹278.06 Cr
Total Debt₹37.79 Cr
D/E0.11x
Interest %234.15%
Curr Interest₹0.96 Cr
Price / range
Close₹120.87
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-1.99%
1W-4.42%
1M-0.86%
3M+89.56%
6M+50.11%
1Y+45.63%
2Y+6.35%
3Y—
5Y—
Diwali+75.84%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue72.43+57.5%73.4265.3054.7445.99217.04
Other Income0.410.850.770.610.852.89
Total Income72.85+55.6%74.2766.0855.3546.83219.94
Interest0.090.080.020.040.140.26
Expenditure-70.95-52.3%-61.55-61.34-55.24-46.58-212.39
PBDT000000
EBITDA2.14+3466.7%12.504.500.260.067.17
Depreciation-0.57-0.55-0.52-0.72-0.51-2.26
EBIT1.57+448.9%11.953.98-0.46-0.454.91
PBT1.89+626.9%12.734.730.110.267.55
Tax-0.44-3.25-1.20-0.08-0.09-2
Equity54.3154.3154.310043.45
OPM2.5917.147.160.200.563.43
Net Profit1.45+752.9%9.483.530.030.175.55
NPM1.9912.765.340.060.362.52
EPS0.27+800.0%1.750.650.010.031.02

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue217.04+62.7%133.36-26.7%182.05
Other Income2.895.439.68
Total Income219.94+58.5%138.79-27.6%191.73
Expenditure-212.39-51.4%-140.24+27.1%-192.49
Interest-0.26-0.18-0.08
PBDT000
EBITDA7.17+253.2%-4.68+44.4%-8.41
Depreciation-2.26-2.02-1.95
EBIT4.91+173.3%-6.70+35.3%-10.36
PBT7.55+620.7%-1.45-93.3%-0.75
Tax-2-0.701.09
Equity43.4543.450
OPM (%)3.43-1.040.00
Net Profit5.55+358.1%-2.15-732.4%0.34
NPM (%)2.52-1.550.00
EPS (Rs)1.020-100.0%0.14
CEPS1.1000.14

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue116.77+152.7%115.2991.9852.4646.20237.47
Other Income0.110.860.170.630.872.32
Total Income116.89+148.3%116.1592.1553.0947.07239.79
Interest0.961.071.0100.141.90
Expenditure-116.22-148.4%-89.95-91.11-56.08-46.79-239.02
PBDT000000
EBITDA5.17+6362.5%29.274.81-3.620.086.39
Depreciation-3.66-2.86-2.930-0.53-6.04
EBIT1.51+435.6%26.411.88-3.62-0.450.35
PBT0.67+139.3%26.191.0500.280.77
Tax-0.26-5.090.71-4.07-0.08-4.04
Equity54.3154.3154.310054.31
OPM0.5722.551.140.000.590.32
Net Profit0.41+105.0%21.101.76-7.060.20-3.27
NPM0.3518.171.91-13.290.42-1.36
EPS0.08+100.0%3.890.3200.040

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue237.47+78.0%133.38-26.7%182.06
Other Income2.325.439.68
Total Income239.79+72.7%138.82-27.6%191.74
Expenditure-239.02-70.3%-140.33+27.1%-192.51
Interest-1.90-0.18-0.08
PBDT000
EBITDA6.39+236.5%-4.68+44.3%-8.40
Depreciation-6.04-2.09-1.97
EBIT0.35+105.2%-6.77+34.7%-10.37
PBT0.77+151.0%-1.51-96.1%-0.77
Tax-4.04-0.691.09
Equity54.3143.450
OPM (%)0.32-1.09-0.40
Net Profit-3.27-48.6%-2.20-787.5%0.32
NPM (%)-1.36-1.590.17
EPS (Rs)00-100.0%0.13
CEPS000.13

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers